NMS-03597812

· Nerviano Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NMS-03597812, covering 2025-10-31 to 2025-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]